Composition
- Active ingredients
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 250MG BASE/5ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 1GM BASE · TabletANDA062390-001 · Discontinued
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 1GM BASE · TabletANDA062408-001 · Discontinued
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 500MG BASE · CapsuleANDA062378-001 · Discontinued
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 500MG BASE/5ML · For suspensionANDA062376-003 · Discontinued
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 125MG BASE/5ML · For suspensionANDA062376-001 · Discontinued
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 250MG BASE/5ML · For suspensionThis page
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA062376.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Ultracef
- Active substance
- cefadroxil/cefadroxil hemihydrate
- Route
- Oral
- Dosage form
- For suspension
- Applicant
- Bristol
- Status
- Discontinued
- Application
- ANDA062376-002